JMP Securities Raises Prothena (NASDAQ:PRTA) Price Target to $85.00
Prothena (NASDAQ:PRTA – Free Report) had its target price upped by JMP Securities from $81.00 to $85.00 in a report released on Friday morning, Benzinga reports. JMP Securities currently has a market outperform rating on the biotechnology company’s stock. A number of other brokerages have also issued reports on PRTA. Royal Bank of Canada decreased […]
More Stories
Primis Financial (FRST) to Release Earnings on Thursday
Primis Financial (NASDAQ:FRST – Get Free Report) is set to issue its quarterly earnings data after the market closes on...
Westwater Resources (NASDAQ:WWR) Receives New Coverage from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Westwater Resources (NASDAQ:WWR – Free Report) in a report issued on Sunday. The brokerage...
GeoPark (NYSE:GPRK) Upgraded to “Strong-Buy” at StockNews.com
StockNews.com upgraded shares of GeoPark (NYSE:GPRK – Free Report) from a buy rating to a strong-buy rating in a research...
Netlist (OTCMKTS:NLST) Upgraded by StockNews.com to “Hold”
StockNews.com upgraded shares of Netlist (OTCMKTS:NLST – Free Report) from a sell rating to a hold rating in a research...
Lear (LEA) Set to Announce Quarterly Earnings on Thursday
Lear (NYSE:LEA – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on...
Healthpeak Properties (NYSE:DOC) Downgraded by StockNews.com to “Sell”
StockNews.com lowered shares of Healthpeak Properties (NYSE:DOC – Free Report) from a hold rating to a sell rating in a...